These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 39239010)
21. Rhino-orbital mucormycosis in a patient with no susceptibility following P.vivax malaria infection-a case report. Prasad S; Gaur A; Mehta A; Kaushal N BMC Ophthalmol; 2022 Oct; 22(1):389. PubMed ID: 36183076 [TBL] [Abstract][Full Text] [Related]
22. Managing mucormycosis in diabetic patients: A case report with critical review of the literature. Beiglboeck FM; Theofilou NE; Fuchs MD; Wiesli MG; Leiggener C; Igelbrink S; Augello M Oral Dis; 2022 Apr; 28(3):568-576. PubMed ID: 33583133 [TBL] [Abstract][Full Text] [Related]
23. First report of rhino-orbital mucormycosis caused by Taghizadeh Armaki M; Jafarzadeh J; Mahdavi Omran S; Bayani M; Tavassoli A; Faeli L; Nosratabadi M; Yaalimadad S; Nikoueian B; Haghani I; Moazeni M; Shokohi T; Taghi Hedayati M; Abastabar M Curr Med Mycol; 2022 Jun; 8(2):49-54. PubMed ID: 36654791 [TBL] [Abstract][Full Text] [Related]
24. Rhino-Orbito-Cerebral Mucormycosis: A Challenging Case. El Hakkouni A; Harrar S; Hachimi A; Mezouari M; Moutaj R Cureus; 2023 Sep; 15(9):e44768. PubMed ID: 37809164 [TBL] [Abstract][Full Text] [Related]
25. Various Treatment Modalities in COVID-19 Associated Facial Mucormycosis and the Need for its Surgical Management: A Systematic Review. Chopra S; Setiya S; Waknis PP; Kale L; Tidke S J Maxillofac Oral Surg; 2023 Mar; ():1-22. PubMed ID: 37362874 [TBL] [Abstract][Full Text] [Related]
26. Is mucormycosis the end? A comprehensive management of orbit in COVID associated rhino-orbital-cerebral mucormycosis: preserving the salvageable. Keshri A; Mathialagan A; Aishwarya A; Ravisankar ; Bhuskute G; Kanaujia V; Singh AK; Singh RK; Dhiman RK; Agarwal R Eur Arch Otorhinolaryngol; 2023 Feb; 280(2):819-827. PubMed ID: 36053359 [TBL] [Abstract][Full Text] [Related]
27. Rhino-Orbital Cerebral Mucormycosis in a Non-diabetic Patient Following COVID-19 Infection: A Case Report and Literature Review. Niazi M; Vittorino I; Thwe H; Alam B; Awosika AO; Omole AE Cureus; 2022 Dec; 14(12):e32884. PubMed ID: 36699798 [TBL] [Abstract][Full Text] [Related]
28. First report of COVID-19-associated rhino-orbito-cerebral mucormycosis in pediatric patients with type 1 diabetes mellitus. Diwakar J; Samaddar A; Konar SK; Bhat MD; Manuel E; Hb V; Bn N; Parveen A; Hajira SN; Srinivas D; S N J Mycol Med; 2021 Dec; 31(4):101203. PubMed ID: 34517273 [TBL] [Abstract][Full Text] [Related]
29. Diabetic ketoacidosis and coronavirus disease 2019-associated mucormycosis: a case report. Monroig V; Tarquinio KM J Med Case Rep; 2022 Oct; 16(1):400. PubMed ID: 36316719 [TBL] [Abstract][Full Text] [Related]
30. A case report on clinical features, diagnosis, and treatment of rhino-orbito-cerebral mucormycosis. Ding JQ; Xie Y Immun Inflamm Dis; 2023 Nov; 11(11):e1080. PubMed ID: 38018593 [TBL] [Abstract][Full Text] [Related]
32. Unnecessary Use of Corticosteroids for managing early mild symptoms of COVID-19 may lead to Rhino-ortibal-cerebral mucormycosis in Patients with Diabetes - a case series from Lahore, Pakistan. Iqtadar S; Hashmat M; Chaudhry MNA; Mumtaz SU; Abaidullah S; Pascual-Figal DA; Khan A Ther Adv Infect Dis; 2022; 9():20499361221097417. PubMed ID: 35547833 [TBL] [Abstract][Full Text] [Related]
33. Short intravenous amphotericin B followed by oral posaconazole using a simple, stratified treatment approach for diabetes or COVID-19-associated rhino-orbito-cerebral mucormycosis: a prospective cohort study. Manesh A; Devasagayam E; Bhanuprasad K; Varghese L; Kurien R; Cherian LM; Dayanand D; George MM; Kumar SS; Karthik R; Vanjare H; Peter J; Michael JS; Thomas M; Mathew BS; Samuel P; Peerawaranun P; Mukaka M; Rupa V; Varghese GM Clin Microbiol Infect; 2023 Oct; 29(10):1298-1305. PubMed ID: 37348653 [TBL] [Abstract][Full Text] [Related]
34. Rhino-Orbital-Cerebral Mucormycosis in a Young Diabetic Patient with COVID-19 in Ethiopia: A Case Report. Alemayehu FM; Abate HK; Soboka TA; Huluka DK; Worke AB; Abrie MT; Dibaba DK; Asnake YB Int Med Case Rep J; 2022; 15():251-257. PubMed ID: 35615254 [TBL] [Abstract][Full Text] [Related]
35. Rhino-Orbital Cerebral Mucormycosis in a Diabetic Patient: An Emergency Medicine Case Report. Sweet R; Hovenden M; Harvey CE; Peterson W; Lott I J Emerg Med; 2023 Mar; 64(3):385-387. PubMed ID: 36932004 [TBL] [Abstract][Full Text] [Related]
36. Hit or Miss: The Dilemma of Specimen Selection for Microbiological Diagnosis of Rhino-Orbital-Cerebral- COVID-Associated Mucormycosis (ROCM-CAM). Jain V; Aggarwal A; Shrimali T; Vishwakarma K; Paul D; Kombade SP; Sharma V; Soni K; Choudhary B; Goyal A; Chugh A; Tiwari S; Sharma DK; Agarwal A; Misra S Infect Disord Drug Targets; 2023; 23(1):e160822207524. PubMed ID: 35975857 [TBL] [Abstract][Full Text] [Related]
37. Imaging features of perineural and perivascular spread in rapidly progressive rhino-orbital-cerebral mucormycosis: A case report and brief review of the literature. Galletta K; Alafaci C; D'Alcontres FS; Maria ME; Cavallaro M; Ricciardello G; Vinci S; Grasso G; Granata F Surg Neurol Int; 2021; 12():245. PubMed ID: 34221576 [TBL] [Abstract][Full Text] [Related]
38. Invasive rhino-orbito-cerebral mucormycosis in a diabetic patient - the need for prompt treatment. Chow V; Khan S; Balogun A; Mitchell D; Mühlschlegel FA Med Mycol Case Rep; 2015 Jun; 8():5-9. PubMed ID: 25750854 [TBL] [Abstract][Full Text] [Related]
39. Rhino-orbital-cerebral mucormycosis: An epidemiological study from a tertiary care referral center in Western India. Patel R; Jethva J; Bhagat PR; Prajapati V; Thakkar H; Prajapati K Indian J Ophthalmol; 2022 Apr; 70(4):1371-1375. PubMed ID: 35326057 [TBL] [Abstract][Full Text] [Related]
40. Successful Treatment of Mucormycosis Caused by Rhizopus arrhizus With Amphotericin B and Itraconazole. Cham CY; P Radhakrishnan A; Chang CY Cureus; 2023 Mar; 15(3):e35814. PubMed ID: 37033497 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]